These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 8942941
1. [Alkaline phosphatase of bone origin in hemodialyzed patients. 110 assays]. Ureña P, Prieur P, Pétrover M. Presse Med; 1996 Oct 05; 25(29):1320-5. PubMed ID: 8942941 [Abstract] [Full Text] [Related]
2. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. Ureña P, Hruby M, Ferreira A, Ang KS, de Vernejoul MC. J Am Soc Nephrol; 1996 Mar 05; 7(3):506-12. PubMed ID: 8704118 [Abstract] [Full Text] [Related]
3. [Interest of bone alkaline phosphatase in hemodialysis patients]. Helal I, Bahlous A, El Younsi F, Ben Hamida F, Abdelmoula J, Belkahia C, Kheder A. Tunis Med; 2008 May 05; 86(5):427-30. PubMed ID: 19469294 [Abstract] [Full Text] [Related]
6. Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism. Lu KC, Tseng CF, Wu CC, Yeung LK, Chen JS, Chao TY, Janckila AJ, Yam LT, Chu P. Blood Purif; 2006 May 05; 24(5-6):423-30. PubMed ID: 16888370 [Abstract] [Full Text] [Related]
7. Bone alkaline phosphatase besides intact parathyroid hormone in hemodialysis patients--any advantage? Jorge C, Gil C, Possante M, Silva E, Andrade R, Santos N, Cruz A, Teixeira R, Ferreira A. Nephron Clin Pract; 2005 May 05; 101(3):c122-7. PubMed ID: 16015001 [Abstract] [Full Text] [Related]
10. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology. Fletcher S, Jones RG, Rayner HC, Harnden P, Hordon LD, Aaron JE, Oldroyd B, Brownjohn AM, Turney JH, Smith MA. Nephron; 1997 May 05; 75(4):412-9. PubMed ID: 9127327 [Abstract] [Full Text] [Related]
11. Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: a randomized prospective multicentre trial. Hayashi M, Tsuchiya Y, Itaya Y, Takenaka T, Kobayashi K, Yoshizawa M, Nakamura R, Monkawa T, Ichihara A. Nephrol Dial Transplant; 2004 Aug 05; 19(8):2067-73. PubMed ID: 15187195 [Abstract] [Full Text] [Related]
15. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients. Coen G, Ballanti P, Bonucci E, Calabria S, Centorrino M, Fassino V, Manni M, Mantella D, Mazzaferro S, Napoletano I, Sardella D, Taggi F. Nephrol Dial Transplant; 1998 Sep 05; 13(9):2294-302. PubMed ID: 9761512 [Abstract] [Full Text] [Related]
16. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism. Lu KC, Ma WY, Yu JC, Wu CC, Chu P. Clin Endocrinol (Oxf); 2012 May 05; 76(5):634-42. PubMed ID: 22007930 [Abstract] [Full Text] [Related]
17. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y. Life Sci; 2005 Jul 22; 77(10):1130-9. PubMed ID: 15978265 [Abstract] [Full Text] [Related]